MariMed, Inc. (MRMD)
0.1071
+0.03
(+42.80%)
USD |
OTCM |
Dec 12, 16:00
MariMed EPS Diluted (Quarterly): -0.0075 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.941M |
| Revenue (Quarterly) | 40.76M |
| Total Expenses (Quarterly) | 43.71M |
| Enterprise Value | 135.01M |
| Gross Profit Margin (Quarterly) | 22.90% |
| Profit Margin (Quarterly) | -7.21% |
| Earnings Yield | -43.32% |
| Operating Earnings Yield | 2.99% |
| Normalized Earnings Yield | -42.11 |